CORY SANTERO: Open Payments
NPI 1740900174 · INVERNESS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$938 in 28 payments from 15 companies in 2025. Trend: 2023 $856 · 2024 $1,034 · 2025 $938
Food & beverage: $938
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $162 |
| AstraZeneca Pharmaceuticals LP | 2 | $141 |
| Alnylam Pharmaceuticals Inc. | 3 | $108 |
| PFIZER INC. | 3 | $56 |
| Merck Sharp & Dohme LLC | 2 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $37 |
| Amgen Inc. | 2 | $31 |
| Novo Nordisk Inc | 1 | $22 |
Products named: JARDIANCE, Kerendia, LOKELMA, ONPATTRO, ELIQUIS, VERQUVO, LifeVest, REPATHA.
Industry payments across FL — which companies pay providers there.
